Arvind Tewari is the Chief Operating Officer of Oxford VR. After studying a BSc and MSc in Molecular and Cellular Biochemistry at Oxford, Arvind worked in M&A at Rothschild focussing on global Consumer and Healthcare businesses. He then worked in private equity during which time he invested over $500m of capital and held numerous Board positions to accelerate the growth of businesses through strategic clarity and operational excellence. At Oxford VR he leads on go to market and product strategy, internal and external operations and business development. Oxford VR is a leading digital therapeutics businesses focussed on treating individuals with severe mental illnesses using clinically-validated virtual reality technology. The business is focussed on the US, UK and Greater China markets where it is working with partners to validate and deploy its VR solutions.

Get in Touch with Arvind Tewari: https://www.linkedin.com/company/oxford-vr-limited/

Subscribe to Healthtech Pigeon 🐦: www.healthtechpigeon.com

Get in touch: www.jamessomauroo.com | www.somx.co.uk

This week, James is joined by Connor Landgraf, CEO and co-founder of Eko, a cardiopulmonary digital health company. Eko is elevating the way clinicians detect and monitor cardiac and respiratory disease by bringing together advanced sensors, patient and provider software, and AI-powered analysis. Connor shares his quick tips with us for entrepreneurs entering the health tech space.

Subscribe to Healthtech Pigeon 🐦www.healthtechpigeon.com

Get in touch: www.jamessomauroo.com | www.somx.co.uk

Dr Abdullah Albeyatti is the CEO and Co-Founder of Medicalchain. Medicalchain is a company that uses blockchain technology to store health records securely. By digitizing health records, Medicalchain aims to empower patients and create a more comprehensive healthcare experience. And, myclinic.com uses Medicalchain technology to allow patients to communicate directly with doctors and share their health records for online consultations.

Dr Albeyatti graduated from Imperial College London as a doctor in 2011 and started his medical career as a surgical trainee in London before moving onto GP Specialty Training. He continues to practice as a GP and is a familiar face in the medical community, speaking at various events. Prior to co-founding Medicalchain, Dr Albeyatti founded Discharge Summary, an application used in hospitals to produce accurate and reliable discharge summaries.

Get in touch with Abdullah: https://www.linkedin.com/in/dr-abdullah-albeyatti-mbbs-bsc-mrcs-ent-mrcgp-49916973/

Subscribe to Healthtech Pigeon 🐦: www.healthtechpigeon.com

Get in touch: www.jamessomauroo.com | www.somx.co.uk

This week, James is joined by Vishaal Virani, a doctor by background now working in digital health. After spending a couple of years in the NHS Vishaal spent some time in healthcare strategy consulting. He then moved into digital health, working at Ada Health, an AI-powered symptom assessment technology. He is now developing digital health innovations for RB, which owns brands such as Nurofen, Gaviscon and Durex. He is also a co-founder of Doctorpreneurs, the global community of healthcare innovators. 

Get in Touch with Vishaal: Dr. Vishaal Virani, MBBS | LinkedIn 

Subscribe to Healthtech Pigeon 🐦: www.healthtechpigeon.com 

Get in touch: www.jamessomauroo.com | www.somx.co.uk

Dr Harro Stokman is CEO & Founder of Kepler Vision Technologies, an Amsterdam-based health-tech start-up which uses artificial intelligence to look after the well-being of humans at night through vision-based body language recognition software. 

Kepler Vision's mission is to make the job of nurses operating in elderly care homes less stressful and more enjoyable by freeing them to focus on providing care through real-time body language recognition. A spin-off company from the University of Amsterdam, Kepler Vision comprises a team of experts across machine learning, computer vision and healthcare - as well as multiple PhDs. Harro is a fascinating guy, and I think an interview with him would be of particular interest to your audience as we enter the second wave of the global health crisis and with many hundreds of thousands of at-risk elderly people still stuck in overstretched care homes facing a Christmas without seeing their families and in danger of contracting the virus.

Get in Touch with Dr Harro: https://nl.linkedin.com/in/harro

Subscribe to Healthtech Pigeon 🐦: www.healthtechpigeon.com

Get in touch: www.jamessomauroo.com | www.somx.co.uk

On this week's Sunday Session, we're asking the question: why has remote monitoring failed? The technology has been around for years, so why isn't remote monitoring ubiquitous across healthcare right now? Are poor quality signals and lack of good-enough AI the answer? My guest is Elina Naydenova. Elina is a biomedical & AI engineer, with a PhD in Machine Learning for Healthcare Innovation from Oxford University. She is the CEO & co-founder of Feebris – a company whose AI-powered platform enables carers & community health workers to detect health conditions early.

Get in Touch with Elina: www.feebris.com | https://www.linkedin.com/in/elinanaydenova/

Subscribe to Healthtech Pigeon 🐦: www.healthtechpigeon.com

Get in touch: www.jamessomauroo.com | www.somx.co.uk

This week, James is joined by Geoff von Maltzahn, CEO and co-founder at Tessera Therapeutics. Tessera is an early-stage biotech start-up that launched this summer with $50M in financing to pioneer a new category in ‘gene writing.’ Going even further than CRISPR, Tessera’s gene writing technology presents the potential to cure genetic disorders, cancers, and even infectious diseases like COVID-19. Geoffrey was awarded a Ph.D. in biomedical engineering and medical physics from MIT.

Get in touch with Geoff: @GVMaltzahn | https://www.linkedin.com/in/geoffrey-von-maltzahn-7a6b755a/

Subscribe to Healthtech Pigeon 🐦www.healthtechpigeon.com

Get in touch: www.jamessomauroo.com | www.somx.co.uk